Applied Therapeutics appoints Baumgartner as Chief Regulatory Officer

Applied Therapeutics (APLT) announced the appointment of Todd Baumgartner, MD, MPH as Chief Regulatory Officer. Dr. Baumgartner will serve as part of the Company’s executive leadership team and will be responsible for leading Applied’s global regulatory strategy. Prior to joining Applied, Dr. Baumgartner served as Senior Vice President of Global Regulatory Affairs, Pharmacovigilance and Biometrics at Ovid Therapeutics (OVID) from 2020 through 2024